BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma

Clinical trial NCT01512251 · COMPLETED

Trial details

NCT number: NCT01512251
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

BRAF Mutant Metastatic Melanoma

Start date: 2012-06-09
Primary completion: 2013-12-13
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.